Cohance Lifesciences Ltd. — documents
130 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_56088_266671_19062020010629_WEB.xm | 9597d835d4745d1e |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_56089_266679_19062020010849_WEB.xm | 638a748b8d4c5832 |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_60437_308136_18082020104814_WEB.xm | 78931489d9a33a38 |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_60439_308139_18082020105250_WEB.xm | a70879e908b10606 |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_62760_353180_31102020012313_WEB.xm | f870a2604cb20a08 |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_62761_353184_31102020012424_WEB.xm | c11001312df716b5 |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_67877_405716_11022021124813_WEB.xm | fa6976180e64da2e |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_67881_405725_11022021125008_WEB.xm | 09ee84703de5ed4a |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_71040_456782_09062021123952_WEB.xm | 32ddaf061f6d4089 |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_71041_456785_09062021124149_WEB.xm | a43e33c5d53570d0 |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_75575_506253_13082021053407_WEB.xm | 77be23a9cf48c4ae |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_75578_506269_13082021053706_WEB.xm | dbe696a01aa2c8f4 |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_77895_552108_06112021053126_WEB.xm | 7be648626e3a6874 |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_77896_552111_06112021053734_WEB.xm | 56c137da96e2110c |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_81614_605003_09022022100611_WEB.xm | 84951ac47b702946 |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_81616_605009_09022022100823_WEB.xm | 9d6aab2280b83b7d |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_84155_652460_10052022124938_WEB.xm | 1cc07397c7be0a78 |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_84159_652478_10052022013435_WEB.xm | 19908d4f0cdb1ba0 |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_639753_3963_09082022104057_WEB.xml | a4d9abfb522d8f6b |
| Results XBRL (NSE) | 2022-06-30 | Consolidated | — | INDAS_639754_3963_09082022104057_WEB.xml | bd3a38f2945c4da0 |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_848845_6441_09112022145242_WEB.xml | 91d43db0c4653fe5 |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_848872_6441_09112022145459_WEB.xml | 0337552ab5fe90a9 |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_88756_787178_07022023111737.xml | cdbf5f1a4054d1e1 |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_88757_787183_07022023112220.xml | cbe3c902348513ea |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_92741_852701_26052023102003.xml | 237cc67827870c8f |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_92742_852706_26052023102334.xml | 6df72cb8818ff4d4 |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_95719_911156_08082023054912.xml | 095804589770a7cd |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_95721_911164_08082023055146.xml | 4d0054bcbed9bdee |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_100334_985234_10112023035500.xml | 39e6f125f4724a4d |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_100340_985256_10112023035805.xml | bd8cef6bd2d3ad9e |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_102421_1045686_06022024034302.xml | 3cef03a84c31f722 |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_102422_1045692_06022024034524.xml | ffaffb3168fda186 |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_111213_1219898_09082024111711.xml | 217726bea27f2d6f |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_111214_1219901_09082024112349.xml | a10e13741cf1f42a |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_115585_1308402_13112024035742.xml | 3b6f8bab7670d82e |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_115592_1308432_13112024040105.xml | 3c29118ea234ce42 |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_120239_1381852_13022025040455.xml | 53e618eb7edb3124 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_120244_1381879_13022025041007.xml | 810a45a1e9581322 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1511682_13082025 | 186124aead95767b |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1511695_13082025 | 4ffa0aa81c2d527f |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1573062_12112025 | 5f9c7a07b7f3b163 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1573067_12112025 | 020e8a8e844f7912 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1695087_17072026 | 4d7d74576e549876 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1695090_17072026 | 39ad266524309e44 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1624684_12022026 | 27c113b8cf7e6517 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1624685_12022026 | c44bf29af6b79279 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1666213_12052026 | 29c02bf20c24d90b |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1666216_12052026 | bbc162d8e1571c91 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1702416_27072026 | 9f3b6c8073561fc9 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1708644_05082026 | c442b21bdf766e22 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1708648_05082026 | 9f4983afb8364c2b |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-06-19T13:33:58 | Main_Ind_As_543064_196202013741.xml | 50b9566e37977278 |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-06-19T13:33:58 | Main_Ind_As_543064_19620201396.xml | 37df6ed1928478f2 |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-08-18T12:27:22 | Main_Ind_As_543064_1882020105052.xml | 1d8c9814c8732ef4 |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-08-18T12:27:22 | Main_Ind_As_543064_188202010532.xml | 108e51426ec5f559 |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-11-04T16:54:53 | Main_Ind_As_543064_31102020132328.xml | 2edaeb49e9940d16 |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-11-04T16:54:53 | Main_Ind_As_543064_31102020132451.xml | 5dcd9ff4ddb97cef |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-11T13:15:09 | Main_Ind_As_543064_1122021124820.xml | 358aea654865789a |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-11T13:15:09 | Main_Ind_As_543064_1122021124915.xml | 718384daa46f7946 |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-06-09T13:20:31 | Main_Ind_As_543064_962021123641.xml | 0b78b74830fb8cf0 |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-06-09T13:20:31 | Main_Ind_As_543064_96202112382.xml | 174f8d5588bf335f |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-08-13T18:16:28 | Main_Ind_As_543064_1382021173335.xml | 6874db76614f7ce2 |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-08-13T18:16:28 | Main_Ind_As_543064_1382021173648.xml | 3e12aabcea438cf2 |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-11-06T17:49:49 | Main_Ind_As_543064_6112021173138.xml | 1de09c4bb997a9e5 |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-11-06T17:49:49 | Main_Ind_As_543064_6112021173633.xml | a6410189c5ae3cbd |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-02-09T11:46:09 | Main_Ind_As_543064_92202210619.xml | 010ab9bc20750d54 |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-02-09T11:46:09 | Main_Ind_As_543064_92202210828.xml | 38b08749b254abe5 |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-10T16:44:12 | Main_Ind_As_543064_1052022125143.xml | ac707fe8600e7821 |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-10T16:44:12 | Main_Ind_As_543064_1052022133337.xml | 4b315485a732b1e1 |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-08-09T16:30:13 | Main_Ind_As_543064_982022104113.xml | a4d9abfb522d8f6b |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-08-09T16:30:13 | Main_Ind_As_543064_982022104212.xml | bd3a38f2945c4da0 |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-09T16:20:00 | Main_Ind_As_543064_9112022131544.xml | 0337552ab5fe90a9 |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-09T16:20:00 | Main_Ind_As_543064_9112022131730.xml | 91d43db0c4653fe5 |
| Annual report | 2020-03-31 | grade A | 2020-08-21T00:00:00 | 64909543064_17_09_20.pdf | f7d07c42ab53aaa9 |
| Annual report | 2021-03-31 | grade B | 2021-08-06T00:00:00 | 69343543064.pdf | 18ad46cc9dfa4629 |
| Annual report | 2022-03-31 | grade B | 2022-07-26T00:00:00 | 73898543064.pdf | 58b5484c43680bdb |
| Annual report | 2023-03-31 | grade A | 2023-11-22T18:03:41.98 | d8a5776c-da4c-473b-b815-a99242494f9a.pdf | e04e0f9c2f55a3f8 |
| Annual report | 2024-03-31 | grade A | 2024-07-16T21:18:08.127 | fec80c4b-d2f3-496a-9e3b-d263ba26c9f7.pdf | 7927dd02867fca8d |
| Annual report | 2025-03-31 | grade A | 2025-08-26T23:02:12.157 | 95288350-4921-470f-b5c3-0b540b626a1b.pdf | 7df021eca091b20f |
| Annual report | 2026-03-31 | grade A | 2026-08-26T20:12:40.923 | 57785e14-bc4d-4ed1-979b-86c824dcebcd.pdf | 182d43b63ba88ce2 |
| Concall | 2022-03-31 | TRANSCRIPT | — | Date_20220513_Cohance Lifesciences Ltd._Concal_Q4FY22.pdf | 5ad768bbcb8fc6e9 |
| Concall | 2022-03-31 | ANALYST_MEET | — | Date_20220608_Cohance Lifesciences Ltd._Concal_Q4FY22.pdf | 984dbca4d2af8e61 |
| Concall | 2022-06-30 | TRANSCRIPT | — | Date_20220816_Cohance Lifesciences Ltd._Concal_Q1FY23.pdf | fc37c130a005e1f5 |
| Concall | 2022-09-30 | TRANSCRIPT | — | Date_20221115_Cohance Lifesciences Ltd._Concal_Q2FY23.pdf | 69ead0cc677cf8f6 |
| Concall | 2022-09-30 | TRANSCRIPT | — | Date_20221230_Cohance Lifesciences Ltd._Concal_Q2FY23.pdf | 6efa6a480c798510 |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230213_Cohance Lifesciences Ltd._Concal_Q3FY23.pdf | 8862109b5dfb67a0 |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230602_Cohance Lifesciences Ltd._Concal_Q4FY23.pdf | f8a60c4757cd5f64 |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230814_Cohance Lifesciences Ltd._Concal_Q1FY24.pdf | 4cd7deb17b89e213 |
| Concall | 2023-09-30 | TRANSCRIPT | — | Date_20231114_Cohance Lifesciences Ltd._Concal_Q2FY24.pdf | 73880ef22d2ea1f6 |
| Concall | 2023-12-31 | TRANSCRIPT | — | Date_20240209_Cohance Lifesciences Ltd._Concal_Q3FY24.pdf | 0bea01c85259ff13 |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20240604_Cohance Lifesciences Ltd._Concal_Q4FY24.pdf | 9a9b6df23bcec807 |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20240814_Cohance Lifesciences Ltd._Concal_Q1FY25.pdf | 94c90892aaa30c6d |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241117_Cohance Lifesciences Ltd._Concal_Q2FY25.pdf | a79f6340f84214f6 |
| Concall | 2024-09-30 | DUPLICATE | — | Date_20241117_Cohance Lifesciences Ltd._Concal_Q2FY25_v2.pdf | 98d4148e03809417 |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241213_Cohance Lifesciences Ltd._Concal_Unresolved.pd | 465ef58c9ecd2cbc |
| Concall | 2024-12-31 | TRANSCRIPT | — | Date_20250218_Cohance Lifesciences Ltd._Concal_Q3FY25.pdf | e92d28d432eda9bf |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250602_Cohance Lifesciences Ltd._Concal_Q4FY25.pdf | 42e0b5254e4feb69 |
| Concall | 2025-06-30 | TRANSCRIPT | — | Date_20250819_Cohance Lifesciences Ltd._Concal_Q1FY26.pdf | e5076b2965789b6c |
| Concall | 2025-06-30 | DUPLICATE | — | Date_20250819_Cohance Lifesciences Ltd._Concal_Q1FY26_v2.pdf | 0a501f2f0ae937a2 |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251101_Cohance Lifesciences Ltd._Concal_Unresolved.pd | 4069c730639a44f7 |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251117_Cohance Lifesciences Ltd._Concal_H1FY26.pdf | 3eccf8b01691497b |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260515_Cohance Lifesciences Ltd._Concal_Q4FY26.pdf | b6b0b41836768452 |
| Concall | 2026-03-31 | DUPLICATE | — | Date_20260515_Cohance Lifesciences Ltd._Concal_Q4FY26_v2.pdf | a32b161776fcfaad |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260811_Cohance Lifesciences Ltd._Concal_Q1FY27.pdf | 47605c8da1160e78 |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161573_530148_12102021051136_WEB.xml | 5142fe0ee417fd35 |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_163890_580781_10012022033921_WEB.xml | 3bcf3702d691b35e |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_166861_634401_13042022060146_WEB.xml | 7cc4f8ff7f822525 |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169489_689801_15072022105400_WEB.xml | 46f551b54102a4c1 |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_172347_737084_20102022045430_WEB.xml | 3e83728ceb3cdc58 |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_173769_761494_11012023114238_WEB.xml | 7ea9c525b1a6b3ae |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176483_817696_13042023043545_WEB.xml | 6efaed601ae62883 |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_178543_879347_11072023024130_WEB.xml | 756c87b582f0c08f |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_182855_964733_21102023115039_WEB.xml | b6cd403203974ce3 |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_184889_1028429_19012024115939_WEB.xm | 9d2b254606acfb5c |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_187344_1096915_17042024065544_WEB.xm | a9fcd39b046f3578 |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_190339_1194889_19072024045421_WEB.xm | b2434e0a8d90bd4e |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_192651_1275821_17102024064659_WEB.xm | 1e153e12a28151ef |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_195668_1353378_20012025061105_WEB.xm | 9f72af5be18f481f |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197858_1417903_17042025080804_WEB.xm | c2c0bfb9713342ba |
| Shareholding XBRL | 2025-05-09 | — | — | SHP_199003_1453859_27052025103555_WEB.xm | 3443aae3e779d0d6 |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1489448_21072025064709_WEB.xml | b36bdf6b4ffc115a |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1550889_16102025071521_WEB.xml | 9b3545221fb5bff5 |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1607146_21012026043514_WEB.xml | 21e13cd3d7bec470 |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1656383_21042026050916_WEB.xml | 5e34ad281218349c |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1695778_17072026082832_WEB.xml | 4dcb384f8833fa28 |
| Related-party XBRL | 2022-09-30 | — | — | RPT_SUVENPHAR_21112022191033.xml | ccd4d2efbdf3f664 |
| Related-party XBRL | 2023-03-31 | — | — | RPT_851908_25052023042228_WEB.xml | 81ba0f075354a1dd |
| Related-party XBRL | 2023-09-30 | — | — | RPT_984008_09112023082753_WEB.xml | 7c3d97e6ace25905 |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1148533_30052024064555_WEB.xml | aab7085c3ca2bd2f |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1307152_12112024081143_WEB.xml | a87dcea37073761e |